Tango Therapeutics, Inc. · NASDAQ:TNGX

Ketchum John B received 4,000 Tango Therapeutics, Inc. shares as an award (Form 4)

Traded Jun 5, 2026 · Filed Jun 8, 2026

On Jun 5, 2026, Ketchum John B (Director) received 4,000 Tango Therapeutics, Inc. shares as an award, leaving 24,937 shares. Filed Jun 8, 2026 (Form 4).

Awarded
4,000 shares
Holding after
24,937 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 5, 2026Common StockAward4,00024,937Direct

Source

View original at SEC

Related